Status:
COMPLETED
Cessation Service Use and Effectiveness for Hospitalized Smokers
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
Oregon Health and Science University
Legacy Health System
Conditions:
Smoking
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this patient-randomized effectiveness trial is to demonstrate that an inpatient technology-supported assisted referral (I-TSAR) and follow-up approach is an effective and cost-effective me...
Detailed Description
The goal of this patient-randomized effectiveness trial is to demonstrate that an inpatient technology-supported assisted referral (I-TSAR) and follow-up approach is an effective and cost-effective me...
Eligibility Criteria
Inclusion
- willing to remain abstinent post discharge
- 1 cpd past 30 days
- active phone
- has a usual source of care
- willing to participate
- willing to provide contact information for follow up
- provide informed consent
Exclusion
- critical care or labor/delivery units
- pregnant or breastfeeding
- physically unable to participate
- cognitively impaired
- no phone
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT01236079
Start Date
December 1 2011
End Date
July 1 2016
Last Update
August 31 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Sunnyside
Clackamas, Oregon, United States, 97015
2
Legacy Emanuel Hospital
Portland, Oregon, United States, 97227
3
Oregon Health & Science Univeristy
Portland, Oregon, United States, 97239